Bulk Price Factory Fasudil Hydrochloride Injection CAS 105628-07-7

• Powder: Yes
• Customized: Customized
• Certification: ISO 9001, USP
• Suitable for: Adult
• State: Solid
• Purity: >99%
• Model NO.: PHA001
• Transport Package: 25kgs Packaging Fiber Drum Outside and Plastic Ba
• Specification: 25kg/Drum, DRUM, Aluminum Foil Bag
• Trademark: ALLRIGHT G. C.
• Origin: Shandong
• Production Capacity: 30000 Kilogram/Kilograms Per Month

Product Description

Product Name	Fasudil Hydrochloride
Chemical Name	6 H-1-(5-isoquinline sulfonyl)-1(H)-1
CAS NO	105628-07-7
MF	C14H17N3O2S·HCl
MV	327.83
Physical Character	White or white like crystalline powder
Functions and Usage	Used for preventing and treating cardiovascular and cerebrovascular disease.
Packing and Storage	Packing: 1kg/bag. Shading seal preservation.
Quality Standard	Appearance: White or white like crystalline powder Acidity: PH4.5-6.0 Residue on Ignition: ≤0.1% Heavy Metals: ≤0.002% Related Substances: Single Impurity≤0.1%                  Total Impurity≤1.0% Water: ≤2.5% Assay: ≥99.0%

Fasudil hydrochloride is a cell-permeable, selective ROCK inhibitor which induces neuroprotection in vitro. Studies suggest that when acting as a ROCK inhibitor, Fasudil reduces neutrophil transendothelial migration by diminishing cytoskeletal rearrangement of endothelial cells. In addition, Fasudil significantly protects against MeHg-induced axonal degeneration and apoptotic cell death in cultured cortical neurons. Alternate studies show that Fasudil plays an important role in osteoblastic differentiation of stromal cells via increasing the mRNA expression of collagen-I, osteocalcin, and bone morphogenetic protein-2 (BMP-2). Furthermore, noggin, a BMP-2 antagonist can reverse the effects of Fasudil induced mRNA expression of collagen-I and osteocalcin. Upon inhibition of Rho-kinase, Fasudil significantly stimulates FGF-2-induced accumulation of vascular endothelial growth factor . Fasudil, Monohydrochloride Salt is an inhibitor of cGKI, MSK1, PKA, PRK2, Rock-2, AMPK, CaMKII, Polycystin-1 and Rsk-1.



Fasudil Hydrochloride is a new drug with a wide range of pharmacological effects, developed by Asahi Kasei Corporation (Japan.) It is a cardiovascular and cerebrovascular drug which improves symptoms of ischemic cerebrovascular disease such as cerebral vasospasm following subarachnoid hemorrhage. It has significant neuroprotective and therapeutic effects for ischemic cerebrovascular disease, and is suited for clinical use, particularly at the grassroots level to reduce mortality and improve quality of life.

Fasudil Hydrochloride is an isoquinoline sulfonamide derivative which can relax separated cerebral blood vessels, inhibit the shrinkage of separated blood vessels caused by calcium influx, inhibit different mechanisms of brain blood vessel contraction from contractile agents, and inhibit intracellular calcium ion activity without reducing calcium ion concentration. Fasudil Hydrochloride is an RHO kinase inhibitor which dilates vessels, reduces tension of endothelial cells, and improves microcirculation of brain tissue without producing or exacerbating diversion of blood to the brain, by increasing activity of myosin light chain phosphatase. At the same time, it can protect nerves against apoptosis and promote their regeneration. Fasudil Hydrochloride promotes recovery of neural function and reduces clinical symptoms.

Appearance	White or off-white crystalline powder
Assay	99%min
Indentification
UV	Meets the requirements
IR	Consistent with reference specturm
Chemical reaction	Meets the requirements
Color or solution	not more intensely colored than refrence solution
Clarify of solution	not more palescent than refrence suspension solution
Related substance	single impurity: 0.1%max
	Total impurity:1.0%max
PH	4.5-6.0
Dimethylformamide	0.088%max
Aether	0.5%max
Methanol	0.3%max
	0.06%max
Moisture	2.5%max
Residue on ignition	0.1%max
Heavy metals	0.002%max